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Edited by Lukas HuberAbstract We previously reported that a novel GRP78-binding
protein (GBP) is predominantly expressed in rat brain and its
expression declines through the aging process. To characterize
its biological function, we established C6 glioblastoma cells that
stably overexpressed GBP. Stable overexpression of GBP atten-
uated cAMP-induced expression of the glial ﬁbrillary acidic pro-
tein (GFAP) gene, which was accompanied by a decrease in
cAMP-induced signal transducer and activators of transcription
3 (STAT3) phosphorylation. Other distinct cAMP-induced
events, including a transient reduction in extracellular signal-reg-
ulated protein kinase phosphorylation and a slowdown in cell
proliferation, were hardly aﬀected by GBP overexpression. Most
importantly, treatment with siRNA against endogenous GBP
markedly downregulated GBP expression in C6 glioblastoma
cells, and dramatically augmented cAMP-induced GFAP mRNA
expression in parallel with hyper-phosphorylation of STAT3.
These results suggest a novel function of GBP in regulating
GFAP gene expression via STAT3 phosphorylation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Previously, we identiﬁed a novel 78 kDa glucose-regulated
protein (GRP78)-binding protein (GBP) gene encoding 1021
amino acids, which was predominantly expressed in rat brain
among various other tissues using PCR-selected cDNA sub-
traction [1]. GBP mRNA is already expressed in the E12 rat
brain, and gradually increases in expression level to reach a
peak during postnatal 0–2 weeks and decreases with age.
GBP-overexpression in Neuro2a cells slightly, but signiﬁ-
cantly, suppressed serum starvation-induced cell death.
GBP transiently expressed in COS7 cells is predominantlyAbbreviations: Erk, extracellular signal-regulated protein kinase; GBP,
GRP78-binding protein; GFAP, glial ﬁbrillary acidic protein; GRP78,
78 kDa glucose-regulated protein; IBMX, 3-isobutyl-1-methylxan-
thine; STAT3, signal transducer and activators of transcription 3
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doi:10.1016/j.febslet.2006.06.028located in the ER among other intracellular organelles. How-
ever, the biological function of GBP cannot be deduced by
amino acid sequence analysis since it contains no known
domains.
The various kinds of cells in the central nervous system
including neuronal and glial lineages are considered to arise
from common precursor cells, which possess the potential to
diﬀerentiate into multiple types of cells [2,3]. Until now,
various mediators present in the environment of the develop-
ing brain have been reported to determine the fate of the
multi-potential precursor cells [4–6]. During development
of brain, astrocyte diﬀerentiation occurs primarily at postna-
tal stages. Extracellular mediators such as bone morphoge-
netic protein-2, ciliary neurotrophic factor, pituitary
adenylate-cyclase activating protein, and the interleukin-6
(IL-6) family of cytokines are reported to promote astrocyte
diﬀerentiation [4,7–11]. The IL-6 family of cytokines trans-
duces its signals to activate a downstream transcription fac-
tor, signal transducer and activators of transcription 3
(STAT3) [12]. During diﬀerentiation of astrocytes from neu-
ronal progenitor cells, activated STAT3 recognizes the spe-
ciﬁc sequence on the glial ﬁbrillary acidic protein (GFAP,
an astrocyte marker) promoter and activates its transcription
[8,9,11,13,14].
The rat C6 glioblastoma cell line is well characterized as a
model of astrocyte diﬀerentiation after treatment with intracel-
lular cAMP elevating stimuli [14–17]. Recently, Takanaga
et al. reported that cAMP-induced GFAP expression in C6
glioblastoma cells is mediated by a STAT3-dependent pathway
[14]. Considering that the expression of GBP mRNA in rat
brain reaches a peak postnatally, we speculated that GBP
might be involved in glial diﬀerentiation and inﬂuence the gene
expression of GFAP during this period. In this report, we ﬁnd
a novel function of GBP in regulating GFAP expression in C6
glioblastoma cells.2. Materials and methods
2.1. Materials
Forskolin and 3-isobutyl-1-methylxanthine (IBMX) were purchased
from Sigma (St. Louis, MO, USA). Antibodies against STAT3, extra-
cellular signal-regulated protein kinase (Erk) and their phosphorylated
forms were purchased from Cell Signaling (Beverly, MA, USA). Anti-
Myc monoclonal antibody (9E10) was obtained from Santa Cruz Bio-
technology (Santa Cruz, CA, USA).blished by Elsevier B.V. All rights reserved.
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The rabbit polyclonal anti-GBP antibody was prepared against a
137 amino acid synthetic peptide corresponding to the C-terminal ami-
no acid residues of the mouse GBP homologue (KIAA1583, 882–1018
aa).
2.3. Cell culture and generation of cells stably expressing Myc-tagged
GBP
Rat C6 glioblastoma cells were maintained in F-10 Nutrient Mixture
(HAM) medium (Invitrogen) containing 7% fetal calf serum and 3%
horse serum. For generation of stable GBP overexpressing and control
cell lines, Myc-tagged GBP or empty vector as a control was transfec-
ted into C6 glioblastoma cells by Lipofectamine-Plus reagent accord-
ing to the manufacturer’s instructions. The transfected cells were
selected and maintained in the presence of G418.
2.4. Morphological study
C6 glioblastoma cells culture were ﬁxed with 4% paraformaldehyde
for 5 min at room temperature and treated with PBS containing 0.2%
TritonX-100. After washing with PBS, cells were stained with rhoda-
mine-phalloidin (Molecular probes) to detect F-actin and were ob-
served with a ﬂuorescence microscope (Olympus).
2.5. Cell proliferation assay
Cell proliferation was quantiﬁed by the WST-1 assay. In brief, C6
glioblastoma cells in 96-well plates were treated with 10 lM forskolin,
10 lM forskolin/100 lM IBMX (F/I) or vehicle for 24 h. Ten microli-
ters of WST-1 solution was added per well at the beginning of the last
hour. The diﬀerence in absorbance at 450 and 620 nm was measured as
an indicator of cell proliferation. Each value of absorbance in control
and GBP-overexpressing cells with no incubation (at 0 h, D0) was de-
ﬁned as 100%, respectively.
2.6. Reverse transcription-polymerase chain reaction
To estimate the mRNA level of each gene by reverse transcription-
polymerase chain reaction (RT-PCR), total RNA was extracted from
cells lysed with Trizol (Invitrogen), and converted to cDNA by reverse
transcription using random ninemers to prime superscript III RNase
RT (Invitrogen) as previously described [18]. Speciﬁc DNAs were
mixed and ampliﬁed with the PCR mixture (EX Taq PCR kit, Takara).
The RT-PCR primers used in this study were as follows: GBP sense
primer, 5 0-GGCTCCCAGTGCTTCAGAGA-3 0; GBP antisense
primer, 5 0-GATCCTCTCCATGTAGTTCCGAA-30; GRP78 sense,
5 0-ACCAATGACCAAAACCGCCT-30; GRP78 antisense, 5 0-GAG-
TTTGCTGATAATTGGCTGAAC-30; GFAP sense, 5 0-CCAAGAT-
GAAACCAACCT-3 0; GFAP antisense, 5 0-CGCTGTGAGGTCTG
GCTT-30; G3PDH sense, 5 0-TCCACCACCCTGTTGCTGTA-30;
3PDH antisense, 5 0-ACCACAGTCCATGCCATCAC-30; b-Actin
sense, 5 0-TGTATGCCTCTGGTCGTACC-30; b-Actin antisense, 5 0-
CAACGTCACACTTCATGATGG-3 0. The typical reaction condi-
tions were 0.5 min at 96 C, 0.5 min at 60 C, and 0.5 min at 72 C.
The results represent 19–34 cycles of ampliﬁcation, after which cDNAs
were separated by electrophoresis on 2.0% agarose gels and visualized
using ethidium bromide. Experiments were repeated and reproducibil-
ity was conﬁrmed.
2.7. Transfection of GBP siRNA
Stealth siRNA against rat GBP (sense, 5 0-CCACCCUUCUGCUU-
CGACACAAUUU-30, and antisense, 5 0-AAAUUGUGUCGAAGC-
AGAAGGGUGG-3 0) and a non-speciﬁc negative control siRNA were
obtained from Invitrogen. In brief, C6 glioblastoma cells (2 · 105 cells
per well in 6-well plates) were transfected with either control or stealth
siRNA against rat GBP (100 nM) using Lipofectamine 2000 reagent
(Invitrogen) in accordance with the manufacturer’s instructions.
Thirty-six hours after transfection, cells were treated with forskolin/
IBMX or vehicle for 20 h.
2.8. Immunoprecipitation and Western blotting analysis
Phosphorylated and non-phosphorylated Erk, STAT3 and Myc-
tagged GBP were analyzed by Western blotting. In brief, cells were
lysed with 20 mM Tris buﬀer, pH 8.0, containing 137 mM NaCl,
2 mM EDTA, 10% (v/v) glycerol, 1 mM phenylmethylsulfonylﬂuoride, 10 lg/ml leupeptin, 10 lg/ml aprotinin, 1 mM sodium
vanadate and 1% (v/v) Triton X-100. The protein concentration was
determined by the Bradford method [19]. Equal amounts of cell
lysates were separated on 8.0% SDS–polyacrylamide electrophoresis
gels, immunoblotted onto polyvinylidene diﬂuoride membrane
(Amersham) and identiﬁed by enhanced chemiluminescence using
antibodies against GBP, Erk, STAT3 and Myc-epitope. For
immunoprecipitation, cells were lysed with 20 mM Tris buﬀer, pH
8.0, containing 150 mM NaCl, 1 mM EDTA, 1% (v/v) NP-40, 1 mM
phenylmethylsulfonyl ﬂuoride, 10 lg/ml leupeptin, 10 lg/ml aprotinin.
After centrifugation, the lysates were immunoprecipitated with anti-
Myc antibody and protein G sepharose FF (Amersham), and analyzed
by Western blotting as described above.3. Results
3.1. Stable overexpression of GBP attenuates cAMP-induced
GFAP mRNA expression in C6 glioblastoma cells
To characterize biological functions of GBP, we ﬁrst estab-
lished C6 glioblastoma cells stably overexpressing GBP. As
shown in Fig. 1A, the approximately 160 kDa protein band
corresponding to Myc-tagged GBP in the lysates was de-
tected by immunoprecipitation and Western blotting with
anti-Myc antibody. As shown in Fig. 1B, morphological
properties of GBP-overexpressing C6 glioblastoma cells were
compared with those transfected with the empty vector
(mock) as a control. GBP-overexpressing C6 glioblastoma
cells had slightly enlarged cell bodies under resting condi-
tions. Cyclic AMP-stimulus caused morphological changes
such as process extension and spindle-shapes in control cells
(mock), but these changes were rarely detected in GBP-over-
expressing C6 glioblastoma cells. On the other hand, the
cAMP-stimulus provoked a growth arrest in both of the cell
types within 8 h according to the WST-1 assay (data not
shown). The proliferation rate of GBP-overexpressing cells
was slightly higher than that of control cells at 24 h after
stimulation (Fig. 1C). In order to investigate whether the
overexpressed GBP inﬂuences the expression levels of GFAP
and GRP78 genes, GBP overexpressing or control cells were
treated with a cAMP-elevating reagent, forskolin and/or
IBMX, and their expression levels were estimated using
RT-PCR analyses. As shown in Fig. 2, GFAP mRNA was
signiﬁcantly induced 24 h after treatment with forskolin
and/or IBMX in the control cells, whereas the GBP-overex-
pressed cells failed to express the GFAP gene. The expression
levels of cell cycle and growth arrest-related genes such as
p21, p27, GADD45 and GADD153 were also analyzed; how-
ever, they were negligibly aﬀected by GBP-overexpression in
C6 glioblastoma cells (data not shown).3.2. Stable overexpression of GBP attenuates cAMP-induced
STAT3 phosphorylation in C6 glioblastoma cells
As STAT3 activation is reported to play a crucial role in
cAMP-induced GFAP expression in C6 glioblastoma cells
[14], we investigated whether GBP-overexpression aﬀects the
cAMP-induced phosphorylation of STAT3 together with Erk
phosphorylation. STAT3 phosphorylation in control cells
was detected 24 h after forskolin/IBMX treatment, whereas
in GBP-overexpressing cells this phosphorylation was mark-
edly lower (Fig. 3). These results corresponded well with the
faint induction of GFAPmRNA by forskolin/IBMX treatment
in the GBP-overexpressing cells. On the other hand, the phos-
Fig. 1. Establishment of C6 glioblastoma cells stably overexpressing GBP. (A) C6 glioblastoma cells stably expressing Myc-tagged GBP (Myc-GBP)
or cells stably transfected with the empty vector (mock) as a control were established by selection with G418 and the expression of Myc-tagged GBP
in the cells was detected by immunoprecipitation of the Myc-epitope and Western blotting as described in Section 2. (B) Control (mock; a, b, c, d) and
GBP-overexpressing cells (GBP; e, f, g, h) were treated with 10 lM forskolin/100 lM IBMX (F/I) (c, d, g, h), or vehicle () (a, b, e, f) for 24 h and
their morphological changes were observed as described in Section 2. Phase contrast (a, c, e, g) and F-actin staining (b, d, f, h). (C) Control (mock)
and GBP-overexpressing cells (GBP) were treated with 10 lM forskolin (F), 10 lM forskolin/100 lM IBMX (F/I), or vehicle () for 24 h, and the
reduction in levels of WST-1 was determined as described in Section 2. Values represent means ± S.E.M. of triplicate cultures and are expressed as the
percentage of the cells before incubation (0 h, D0).
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Fig. 2. GBP-overexpression attenuated cAMP-induced GFAPmRNA expression in C6 glioblastoma cells. (A) Control and GBP-overexpressing cells
were treatedwith 10 lMforskolin to detect expression levels ofGFAP,GBPandGRP78genes at the indicated time. (B)Control andGBP-overexpressing
cells were treated with 10 lM forskolin (F), 10 lM forskolin/100 lM IBMX (F/I), or vehicle () for 24 h to detect expression levels of GFAP and GBP
genes. Total RNA was isolated from the cells and their expression levels in each clone were analyzed by RT-PCR as described in Section 2.
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Fig. 3. GBP-overexpression suppressed cAMP-induced STAT3 phos-
phorylation in C6 glioblastoma cells. Control (mock) and GBP-
overexpressing cells (GBP) were treated with 10 lM forskolin/100 lM
IBMX (F/I) for the indicated time. Cell lysates of each clone were
analyzed by Western blotting using antibodies against phospho-Erk1/
2, Erk1/2, phospho-STAT3, STAT3 and Myc-epitope as described in
Section 2.
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within 0.5 h and partially recovered 24 h after forskolin/IBMX
treatment. The phosphorylation pattern of Erk up to 24 h was
similar between the two cell lines.
3.3. Suppression of intrinsic GBP augments cAMP-induced
GFAP mRNA expression
Finally, we examined whether the suppression of intrinsic
GBP enhances GFAP gene induction in C6 glioblastoma
cells. The amount of endogenous GBP in C6 glioblastoma
cells transfected with siRNA against rat GBP was less than
half of that of control cells transfected with non-speciﬁc
siRNA. These phenomena occurred independently of for-
skolin/IBMX stimulation (Fig. 4A). On the contrary,
GBP-speciﬁc siRNA transfection facilitated GFAP gene
expression and STAT3 phosphorylation only when receiving
the cAMP-elevating stimuli (Fig. 4B). These results imply
that GBP negatively regulates cAMP-induced GFAP tran-
scription through the STAT3 signaling pathway in C6
glioblastoma cells.GFAP
GBP
siRNA
F/I
-
+
+
+
-
-
+
-
A
pho
B
Fig. 4. Downregulation of GBP by siRNA accelerated cAMP-induced GFAP
transfection of siRNA against GBP or control siRNA, cells were treated with
expression levels of GFAP, GBP and b-Actin mRNAs in cells treated with ea
levels in each case were analyzed by RT-PCR as described in Section 2. (B)
analyzed by Western blotting as described in Section 2.4. Discussion
GBP is predicted to have two transmembrane regions, a
proline- and a glutamic acid-rich region, but its sequence of-
fered few clues to its possible functions. Consistent with our
previous results, we estimated the expression level of GBP
mRNA in primary cultured neurons, astrocytes and microg-
lial cells prepared from rat embryonic cerebral cortex by RT-
PCR. Among the three types of primary cultured cells, the
highest expression of GBP mRNA was observed in primary
cultured neurons whereas lower amounts of GBP mRNA
were detected in the other two cell types (data not shown).
Considering that GBP mRNA is detected in E12 brain and
reaches a peak around postnatal 0–2 weeks, GBP may take
part in the development and maintenance of various types
of cells in the brain.
In this study, we demonstrated that GBP plays a crucial
role in GFAP expression in C6 glioblastoma cells and nega-
tively regulates GFAP transcription only when the cAMP
concentration in the cells is elevated. Stable expression of
the mouse GBP homologue, KIAA1583, in C6 glioblastoma
cells also reduced cAMP-induced GFAP mRNA expression
(data not shown). On the contrary, the suppression of intrin-
sic GBP was found to augment the expression of cAMP-in-
duced GFAP mRNA. In regard to this augmentation, the
IL-6 family of cytokines is reported to enhance GFAP tran-
scription through the STAT3 binding site on the GFAP pro-
moter [13,14]. STAT3 is a common downstream transcription
factor of the IL-6 family of cytokines, and participates in
various glial functions including diﬀerentiation, inﬂamma-
tion, and proliferation [8,9,11,20]. Takanaga et al. reported
that cAMP-induced GFAP expression in C6 glioblastoma
cells is mediated by autocrine IL-6 [14] signaling. In our pres-
ent study, the remarkable increased expression level of GFAP
mRNA resulting from siRNA-induced downregulation of
GBP was accompanied by hyper-phosphorylation of STAT3.
On the other hand, the cAMP-induced STAT3 phosphoryla-
tion was diminished in C6 glioblastoma cells by overexpress-
ing GBP. These results suggest that GBP might act upstream
of STAT3 pathway, however, the precise mechanisms remain
to be determined.
Recently, it was reported that apoptosis signal-regulated ki-
nase 1 represses GFAP promoter activity through a p38spho-STAT3
STAT3
siRNA
F/I
-
+
+
+
-
-
+
-
GBP
mRNA expression in C6 glioblastoma cells. (A) Thirty-six hours after
10 lM forskolin/100 lM IBMX (F/I) or vehicle () for 20 h to detect
ch siRNA. Total RNA was isolated from the cells and their expression
Phospho-STAT3, STAT3 and intrinsic GBP in each cell lysates were
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hippocampus-derived progenitor cells [21]. However, a p38
MAPK inhibitor did not restore the lower expression level of
cAMP-induced GFAP mRNA in GBP-overexpressing cells in
our preliminary experiments, which is consistent with the pre-
vious report that the p38 MAPK inhibitor had no eﬀect on
cAMP-induced GFAP promoter activity in C6 glioblastoma
cells [14]. In addition, phosphatidylinositol 3-kinase (PI3K) is
reported to be required for cAMP-induced GFAP expression
in C6 glioblastoma cells [22], whereas protein kinase B
(PKB), a downstream target of PI3K, is reported to negatively
regulate this expression in the same cells [23]. Thus, the precise
mechanisms by which PI3K and/or PKB regulate GFAP
expression are still unclear. Further characterization of GBP
may uncover a complex link between GBP, PI3K-PKB and
STAT3 in the regulation of GFAP expression in C6 glioblas-
toma cells.
In conclusion, we have demonstrated a novel function of
GBP in regulating cAMP-induced GFAP transcription
through the STAT3 signaling pathway in C6 glioblastoma
cells. We believe that further studies to understand how GBP
regulates STAT3 phosphorylation may reveal novel functional
domains of GBP. STAT3 is reported to participate not only in
the expression of various genes, such as inﬂammatory cyto-
kines and adhesion molecules, but also in apoptosis and diﬀer-
entiation of neurons and their progenitor cells [20,24–26].
Therefore, further characterization of GBP might provide
new insights into its crucial roles in the developing brain and
neurodegenerative diseases.Acknowledgements: This research was supported in part by the Sasag-
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